California Firm Uses Biotech Corn to Develop Hepatitis B Vaccine

John Howard, founder of Applied Biotechnology Institute, is experimenting with biotech corn to develop affordable, and easy-to-administer vaccine for hepatitis B. According to Howard, the goal of his company is to produce oral vaccine in a form of wafer, which would be cheaper compared to other vaccines, and would not need cold storage.

"If we are successful in this, it could be a really big deal," Howard said. "A small farm could vaccinate the world."

Read more at http://www.vaccinationnews.org/content/daily-news-2014-11-24 and http://www.appliedbiotech.org/?page_id=35=1.


 

This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)

Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS

Article Search: